Amphastar Pharmaceuticals (AMPH) Debt Ratio (2013 - 2026)

Amphastar Pharmaceuticals' Debt Ratio history runs 14 years deep, the most recent figure standing at 0.37 for Q1 2026.

• In Q1 2026, Debt Ratio changed 0.12% year-over-year to 0.37; the TTM figure through Mar 2026 stood at 0.37 (changed 0.12% YoY), while the FY2025 annual figure was 0.37, down 1.81% from the prior year.
• Debt Ratio was 0.37 for Q1 2026 at Amphastar Pharmaceuticals, down from 0.37 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.41 in Q3 2023 to a low of 0.1 in Q1 2023.
• Historically, Debt Ratio has averaged 0.3 across 5 years, with a median of 0.37 in 2025.
• The sharpest annual moves came in 2022 and 2023: Debt Ratio dropped 12.76% in 2022, then surged 296.95% in 2023.
• A 5-year view of Debt Ratio shows it stood at 0.1 in 2022, then soared by 281.32% to 0.39 in 2023, then dropped by 2.17% to 0.38 in 2024, then dropped by 1.81% to 0.37 in 2025, then fell by 0.97% to 0.37 in 2026.
• The last three Debt Ratio figures came in at 0.37 (Q1 2026), 0.37 (Q4 2025), and 0.37 (Q3 2025), per Business Quant data.